Nourkami-Tutdibi N - Search Results

1

High-dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival-The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experience.

Furtwängler R, Kager L, Melchior P, Rübe C, Ebinger M, Nourkami-Tutdibi N, Niggli F, Warmann S, Hubertus J, Amman G, Leuschner I, Vokuhl C, Graf N, Frühwald MC. Furtwängler R, et al. Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26746. Epub 2017 Aug 26. Pediatr Blood Cancer. 2018. PMID: 28843054 Clinical Trial.

2

Controlled Prospective Study on the Use of Systematic Simulator-Based Training with a Virtual, Moving Fetus for Learning Second-Trimester Scan: FESIM III.

Freundt P, Nourkami-Tutdibi N, Tutdibi E, Janzing P, von Ostrowski T, Langer M, Zemlin M, Steinhard J. Freundt P, et al. Ultraschall Med. 2023 Aug;44(4):e199-e205. doi: 10.1055/a-1984-8320. Epub 2023 Mar 7. Ultraschall Med. 2023. PMID: 36882110 Free PMC article.

3

Controlled prospective study on ultrasound simulation training in fetal echocardiography: FESIM II.

Janzing P, Nourkami-Tutdibi N, Tutdibi E, Freundt P, von Ostrowski T, Langer M, Zemlin M, Steinhard J. Janzing P, et al. Arch Gynecol Obstet. 2024 Jun;309(6):2505-2513. doi: 10.1007/s00404-023-07133-2. Epub 2023 Jul 16. Arch Gynecol Obstet. 2024. PMID: 37454353 Free PMC article.

4

Multicenter study identified molecular blood-born protein signatures for Wilms Tumor.

Schmitt J, Heisel S, Keller A, Leidinger P, Ludwig N, Habel N, Furtwängler R, Nourkami-Tutdibi N, Wegert J, Grundy P, Gessler M, Graf N, Lenhof HP, Meese E. Schmitt J, et al. Int J Cancer. 2012 Aug 1;131(3):673-82. doi: 10.1002/ijc.26419. Epub 2011 Oct 23. Int J Cancer. 2012. PMID: 21913182

5

Autoantibody signature differentiates Wilms tumor patients from neuroblastoma patients.

Schmitt J, Keller A, Nourkami-Tutdibi N, Heisel S, Habel N, Leidinger P, Ludwig N, Gessler M, Graf N, Berthold F, Lenhof HP, Meese E. Schmitt J, et al. PLoS One. 2011;6(12):e28951. doi: 10.1371/journal.pone.0028951. Epub 2011 Dec 16. PLoS One. 2011. PMID: 22194956 Free PMC article.

6

Treatment-independent miRNA signature in blood of Wilms tumor patients.

Schmitt J, Backes C, Nourkami-Tutdibi N, Leidinger P, Deutscher S, Beier M, Gessler M, Graf N, Lenhof HP, Keller A, Meese E. Schmitt J, et al. BMC Genomics. 2012 Aug 7;13:379. doi: 10.1186/1471-2164-13-379. BMC Genomics. 2012. PMID: 22871070 Free PMC article.

7

Circulating serum miRNAs as potential biomarkers for nephroblastoma.

Ludwig N, Nourkami-Tutdibi N, Backes C, Lenhof HP, Graf N, Keller A, Meese E. Ludwig N, et al. Pediatr Blood Cancer. 2015 Aug;62(8):1360-7. doi: 10.1002/pbc.25481. Epub 2015 Mar 18. Pediatr Blood Cancer. 2015. PMID: 25787821

8

ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study.

Vokuhl C, Nourkami-Tutdibi N, Furtwängler R, Gessler M, Graf N, Leuschner I. Vokuhl C, et al. Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26925. Epub 2017 Dec 29. Pediatr Blood Cancer. 2018. PMID: 29286563 Clinical Trial.

9

Plasma levels of osteopontin from birth to adulthood.

Nourkami-Tutdibi N, Graf N, Beier R, Zemlin M, Tutdibi E. Nourkami-Tutdibi N, et al. Pediatr Blood Cancer. 2020 Jul;67(7):e28272. doi: 10.1002/pbc.28272. Epub 2020 Mar 29. Pediatr Blood Cancer. 2020. PMID: 32227460

10

Persistent aseptic meningitis in a child-think patch.

Nourkami-Tutdibi N, Simon A, Furtwängler R, Graf N, Yilmaz U, Oertel J, Meyer S. Nourkami-Tutdibi N, et al. Wien Med Wochenschr. 2021 Feb;171(1-2):38-40. doi: 10.1007/s10354-020-00765-y. Epub 2020 Jul 10. Wien Med Wochenschr. 2021. PMID: 32651688 English.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters